All
Legislation to improve patient safety; create “safe environment”
September 1st 2004Dermatologists and other healthcare providers are soon expected to have a formal mechanism for reporting medical errors and near misses without having to worry that the information will be used against them in a lawsuit.
Researchers make inroads in combination immunotherapy for melanoma
September 1st 2004New York - Melanoma-derived peptide vaccines are currently an exciting area of melanoma immuno-therapy research, according to Douglas J. Schwartzentruber, M.D., medical director and director of the Center for Cancer Care at Goshen Health System, Goshen, Ind., speaking at the Society of Surgical Oncology annual meeting.
Novel patch delivers local anesthesia with convenience, quickness, safety
September 1st 2004New York-An easy-to-use, self-warming patch containing lidocaine and tetracaine provides effective local anesthesia for minor dermatological procedures in adult patients, said Brian Berman, M.D., Ph.D, at the American Academy of Dermatology's Academy '04 meeting here.
Melasma treatments - from frustration to fruition?
September 1st 2004Eilat, Israel - For the last 50 years, hydroquinone has been the reference of treatment in hyperpigmentations, and more recently, combination formulas, peelings and adjuvant therapies including sunscreens containing the drug, show promise. However, topical agents have yet to prove a constant and uncontested efficiency, said Daphne Thioly-Bensoussan M.D., during the 28th Annual Meeting of the Israeli Conference of Dermatology and Venerology.
Tacrolimus bests pimecrolimus for treatment of AD, study says
September 1st 2004Kona, Hawaii - Tacrolimus ointment is superior to pimecrolimus cream in treating atopic dermatitis, according to recent trial data reported by Alan Fleischer, M.D., during the 28th Annual Hawaii Dermatology Seminar here. Both calcineurin inhibitors have identical modes of action and identical metabolism, and bind to the same FKBP receptor. "But pimecrolimus has one-third the binding affinity of tacrolimus," he says.
Savvy physician takes walk on entrepreneurial side
September 1st 2004Finally - and perhaps most crucial, says Dr. Goode - there is this question: Is there anything like the new device available? Because if there isn't, the new device could draw the attention of manufacturing or distributing companies.
Success starts outside operating room
August 1st 2004Stanford, Calif. - To be truly successful in a cosmetic surgery dermatology practice, it is important to think beyond garnering surgical ability. While such ability is essential, it is not the only aspect of a practice that surgeons should think about, says David R. Harris, M.D., a clinical professor at Stanford University School of Medicine.
Attending to many aspects of patient pain
August 1st 2004Orlando, Fla. - Pain has several components - both sensory and emotional - and it is an experience that varies by individual. The ability to control pain effectively is crucial to a good dermatology practice. That was the message Christopher B. Zachary, F.R.C.P. presented recently at the Skin Disease Education Foundation Cosmetic Dermatology Symposium here.
Radiance FN finds special niche in facial augmentation
August 1st 2004Stanford, Calif. - Radiance FN (BioForm) is an excellent injectable material for augmentation of minor defects, particularly in the midface, although accumulating experience might point to additional roles for this relatively new addition to the filler armamentarium, says Hayes B. Gladstone, M.D.